Smith & Nephew rolls out new dissolvable suture anchor; Cantel grabs Israeli colonoscopy device maker;

@FierceMedDev: ICYMI: Roche's Ventana to concoct companion Dx tests for Incyte's cancer drugs. More | Follow @FierceMedDev

@MarkHFierce: Biocept becomes the latest Dx company to outline its IPO terms - full speed ahead. Story | Follow @MarkHFierce

@MichaelGFierce: ICYMI: Gold nanoparticles first to deliver RNA to brain tumors. More from FierceDrugDelivery | Follow @MichaelGFierce

> Smith & Nephew ($SNN) is beginning the U.S. rollout of a new suture anchor for arthroscopic surgery that's made of a biocomposite material absorbed into the body within two years. Release

> A judge declared a mistrial in a malpractice case against a former Maryland cardiologist and the former owners of St. Joseph Medical Center that alleged the unnecessary use of stents that injured a patient. Story

> Surgical device maker Globus Medical faces an FDA warning letter for alleged quality system and medical device reporting violations at its Audubon, PA, facility. Warning letter

> Kips Bay Medical, a maker of vein support devices for coronary artery bypass grafting surgery, lost $1.6 million in the 2013 quarter, versus a $1.4 million net loss over the same period in 2012. Release

> Veniti gained a CE mark for two products: its Vici venous stent to treat blocked veins, and a new varicose vein ablation device. Release

> Cantel Medical ($CMN) snatched up an Israeli company that developed a device to help improve colonoscopy procedures. Story

Biotech News

@FierceBiotech: Novartis R&D will ax 500 staffers, boost Boston in global realignment. More | Follow @FierceBiotech

@JohnCFierce: Geron shares double on imetelstat data. Quite a reversal of fortune for Geron. Story | Follow @JohnCFierce

@DamianFierce: Medtronic wins FDA approval to use its software with competitors' tech. More | Follow @DamianFierce

@EmilyMFierce: Next Generation: Cancer Drug in Disguise. Article | Follow @EmilyMFierce

> Shire slashes R&D ops, refocuses pipeline as it restructures in Europe, U.S. News

> GlaxoSmithKline toes the line in Breo launch. Item

Pharma News

@FiercePharma: Biggest new news online: Will Merck be next to join Big Pharma's asset sale parade? Story | Follow @FiercePharma

@CarlyHFierce: Does the Justice Department's off-label marketing enforcement actually deter bad behavior? With GSK, maybe. More | Follow @CarlyHFierce

> J&J whistleblowers to collect record $168M share of DoJ settlement. Story

> Roche's new Gazyva beats predecessor Rituxan in staving off CLL. News

> Top Adcock shareholder nixes CFR offer, endangering $1.3B deal. More

Pharma Manufacturing News

> Hospira CEO looks to better days as 'swamp draining' nears end. News

> Wholesaler McKesson settles another price-manipulation suit. Article

> FDA finally lifts warning letter on AMRI fill/finish facility. More

> Visa woes still stalling FDA plans for China inspections. Story

> Pfizer contractors testing new methods to clean up old production site. News

> Nosco hiring 51 staff for packaging and labeling plant. Item

Vaccines News

> Merck readies FDA submission for son of Gardasil. News

> Takeda, Boehringer invest to move CMV vaccine into clinic. Story

> European scientists join Sanofi, Pfizer in C. diff vaccine race. Article

> Study finds one HPV vaccine dose gives strong, durable immune response. News

> WHO massively scales up Middle East polio immunization plan. Story

> Shipping snafu prompts Navy review of vaccination procedures. Item

Suggested Articles

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.